Effects of replacement therapy on indices of atherosclerosis in subclinical hypothyroidism

Effects of replacement therapy on indices of atherosclerosis in subclinical hypothyroidism - Effects of replacement therapy on indices of atherosclerosis in subclinical hypothyroidism

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027613

Enrollment

200

Registered

2017-06-02

Start date

2017-05-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subclinical hypothyroidism

Interventions

levothyroxine treatment no medication

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with subclinical hypothyroidism

Exclusion criteria

Exclusion criteria: 1. patients with diabetes mellitus 2. patients with chronic kidney disease group 4 and greater 3. patients with moderate or severe liver dysfunction 4. patients with past history of myocardial infacrction, stroke, or Arteriosclerosis obliterans 5. pregnant women or women who are possibly pregnant

Design outcomes

Primary

Measure	Time frame
improvement of indices of atherosclerosis for 3 years	—

Countries

Japan

Contacts

Public ContactSatoshi Morimoto

Tokyo Women's Medical University Department of Internal Medicine II, Endocrinogloy and Hypertension

smorimoto@endm.twmu.ac.jp03-3353-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026